Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients.

Kilian-Simon BaumannVeronika FlattenUli WeberStefan LautenschlägerFabian EberleKlemens ZinkRita Engenhart-Cabillic

Published in: Radiation oncology (London, England) (2019)

Effects of the Bragg peak degradation due to lung tissue were investigated for lung cancer treatment plans in proton therapy. This study confirms that these effects are clinically tolerable to a certain degree in the current clinical context considering the various more critical dose uncertainties due to motion and range uncertainties in proton therapy.

Keyphrases

mass spectrometry
high speed
single molecule